1. Main Content / Key Points
    (Break into 2–4 main sections depending on topic)
    • Section 1: Describe challenges for biomarker development
    • Section 2: Describe analytic and pre-analytic validation of PTEN IHC
    • Section 3:  Describe clinical validation of PTEN as a prognostic marker
    • Section 4: Describe uses for PTEN as a diagnostic biomarker
    • Section 5: Describe PTEN as a predictive biomarker
Session date: 
06/04/2026 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 ABPath Lifelong Learning
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Tamara Lotan, M.D.